Stay updated with breaking news from Kodiak Sciences Nasdaq. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PALO ALTO, Calif., May 29, 2024 /PRNewswire/ -- Kodiak Sciences Inc. , a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a...
Tarcocimab clinical and non-clinical data highlight strong 6-month efficacy profile in diabetic retinopathy patients and continued favorable safety profile.KSI-501 clinical and non-clinical data...
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection...